AZD0022 drug page Clinical trials

Trials with AZD0022

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
4Countries
17Planned patients

Showing 1–1 of 1

A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation
Finished Phase 1 17 patients NCT06599502

This is a first-in-human, modular, Phase I/IIa, open-label, multi-centre study to assess the safety, tolerability, PK, and preliminary efficacy of AZD0022 monotherapy in combination with other anti-cancer agents in participants with tumour…

United States, Australia, Japan, South Korea Oct 2024 – Jun 2026 Interventional
Combined with: Cetuximab